[go: up one dir, main page]

AU3003701A - Inhibitors of helicobacter pylori induced gastrointestinal diseases - Google Patents

Inhibitors of helicobacter pylori induced gastrointestinal diseases

Info

Publication number
AU3003701A
AU3003701A AU30037/01A AU3003701A AU3003701A AU 3003701 A AU3003701 A AU 3003701A AU 30037/01 A AU30037/01 A AU 30037/01A AU 3003701 A AU3003701 A AU 3003701A AU 3003701 A AU3003701 A AU 3003701A
Authority
AU
Australia
Prior art keywords
inhibitors
helicobacter pylori
gastrointestinal diseases
induced gastrointestinal
pylori induced
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU30037/01A
Inventor
Dorian Bevec
Christian Wallasch
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Axxima Pharmaceuticals AG
Original Assignee
Axxima Pharmaceuticals AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Axxima Pharmaceuticals AG filed Critical Axxima Pharmaceuticals AG
Publication of AU3003701A publication Critical patent/AU3003701A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/275—Nitriles; Isonitriles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A61K31/4152—1,2-Diazoles having oxo groups directly attached to the heterocyclic ring, e.g. antipyrine, phenylbutazone, sulfinpyrazone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
    • A61K31/5513—1,4-Benzodiazepines, e.g. diazepam or clozapine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7088—Compounds having three or more nucleosides or nucleotides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Oncology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Emergency Medicine (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AU30037/01A 1999-11-19 2000-11-17 Inhibitors of helicobacter pylori induced gastrointestinal diseases Abandoned AU3003701A (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
EP99123042 1999-11-19
EP99123042 1999-11-19
US44801399A 1999-11-23 1999-11-23
US09448013 1999-11-23
PCT/EP2000/011444 WO2001035899A2 (en) 1999-11-19 2000-11-17 Inhibitors of helicobacter pylori induced gastrointestinal diseases

Publications (1)

Publication Number Publication Date
AU3003701A true AU3003701A (en) 2001-05-30

Family

ID=26153172

Family Applications (1)

Application Number Title Priority Date Filing Date
AU30037/01A Abandoned AU3003701A (en) 1999-11-19 2000-11-17 Inhibitors of helicobacter pylori induced gastrointestinal diseases

Country Status (4)

Country Link
EP (1) EP1229925A2 (en)
JP (1) JP2003513995A (en)
AU (1) AU3003701A (en)
WO (1) WO2001035899A2 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1174129A1 (en) * 2000-07-17 2002-01-23 Zenner, Hans Peter, Prof. Dr. med. Use of a matrix-metalloprotease inhibitor for the treatment of cancer
WO2003075947A1 (en) * 2002-03-08 2003-09-18 MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. Use of egfr transactivation inhibitors in human cancer
CA2717193C (en) 2008-02-29 2022-08-16 Acorda Therapeutics, Inc. Method for achieving desired glial growth factor 2 plasma levels
RU2693484C1 (en) 2013-11-22 2019-07-03 СиЭль БАЙОСАЕНСИЗ ЭлЭлСи Gastrin antagonists for treating and preventing osteoporosis
WO2018151285A1 (en) * 2017-02-20 2018-08-23 学校法人順天堂 Prophylactic or therapeutic drug for itching skin diseases

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9513551D0 (en) * 1995-07-04 1995-09-06 Pharmacia Spa Anti-bacterial synergistic composition
JP3718890B2 (en) * 1995-12-28 2005-11-24 味の素株式会社 N-benzoylproline ester derivative
JP2002505665A (en) * 1997-04-30 2002-02-19 メリュー・オラバックス Anti-Helicobacter vaccine composition containing Th1-type adjuvant
JPH11124368A (en) * 1997-10-22 1999-05-11 Takeda Chem Ind Ltd Bioactive substance, its production and agent
PT1042305E (en) * 1997-12-22 2005-10-31 Bayer Pharmaceuticals Corp INHIBITION OF KINASE P38 USING SYMMETRICAL AND ASYMMETRIC DIFENILURE
JPH11189529A (en) * 1997-12-25 1999-07-13 Toray Ind Inc Anti-helicobacter pylori agent
WO1999055335A1 (en) * 1998-04-30 1999-11-04 Basf Aktiengesellschaft Substituted tricyclic pyrazole derivatives with protein kinase activity
DE69916273T2 (en) * 1998-06-18 2005-05-19 Vecta Ltd. USE OF GASTRIN FRAGMENTS OR SYNTHETIC ANALOGS OF GASTRIN FOR THE MANUFACTURE OF A MEDICAMENT FOR TREATING HELICOBACTER PYLORI-ASSOCIATED DISORDER

Also Published As

Publication number Publication date
WO2001035899A3 (en) 2001-12-13
EP1229925A2 (en) 2002-08-14
WO2001035899A2 (en) 2001-05-25
WO2001035899A9 (en) 2002-09-19
JP2003513995A (en) 2003-04-15

Similar Documents

Publication Publication Date Title
AU3864300A (en) Chewable soft capsule
AU2001277163A1 (en) Ingestible electronic capsule
AU2002315779A1 (en) Soft capsules
AU2001271559A1 (en) Drillable bridge plug
AU3867400A (en) Methods of using bioelastomers
AU2453300A (en) Subsea completion apparatus
AU4198500A (en) Suture-passing forceps
AU2929700A (en) Tong
AU2002363799A1 (en) Method for diagnosis of helicobacter pylori infection
AU1746601A (en) Method of covalent coupling
AU3495200A (en) Actuation of downhole devices
AU6599800A (en) Endoscope
AU2001236052A1 (en) Urease inhibitors
GB0017239D0 (en) Detection of helicobacter pylori
AU1716500A (en) Non-invasive detection of helicobacter pylori infection
AU2002349670A1 (en) Catheter kit for gastric ulcer
AU7817500A (en) Method of tumor imaging
EP1172224A4 (en) Substrate of recording
AU3003701A (en) Inhibitors of helicobacter pylori induced gastrointestinal diseases
AU7445100A (en) Sebum production inhibitors
GB2355657B (en) Inhibitors Of Gastric Acid Secretion
AU2002360790A1 (en) Compositions and methods for the therapeutic use of an atonal-associated sequence for a gastrointestinal condition
AU5838100A (en) Bio-regeneration bracelet
AU2001268885A1 (en) Helicobacter dd-heptosyltransferase
AU4990300A (en) Rapidly deployable cuff device

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase